Diaceutics (DIUXF) Stock Forecast & Price Target
DIUXF Analyst Ratings
DIUXF Stock 12 Month Forecast
Average Price Target
$2.88▲(24.91% Upside)Detailed List of Analyst Forecasts
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Hayley Palmer | Canaccord Genuity | $2.88 | buy | 24.91%Upside | Reiterated | 09/22/26 | ||
| Shore Capital | $2.41→$2.88 | buy | 24.91%Upside | Reiterated | 01/15/26 |
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Hayley Palmer | 09/22/26 | $2.88 | buy | 24.91%Upside | Reiterated | Canaccord Genuity | ||
| 01/15/26 | $2.41→$2.88 | buy | 24.91%Upside | Reiterated | Shore Capital |
Best Analysts Covering Diaceutics
Copying Hayley Palmer's trades and holding each position for 3 Months would result in 18.18% of your transactions generating a profit, with an average return of +2.78% per trade.
Copying Hayley Palmer's trades and holding each position for 1 Year would result in 36.36% of your transactions generating a profit, with an average return of +7.63% per trade.
Copying Hayley Palmer's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +34.72% per trade.
DIUXF Analyst Recommendation Trends
| Rating | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 2 | 2 | 2 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 2 | 2 | 2 | 1 | 1 |
In the current month, DIUXF has received 1 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. DIUXF average Analyst price target in the past 3 months is 2.88.
DIUXF Financial Forecast
DIUXF Earnings Forecast
Next quarter’s earnings estimate for DIUXF is $0.04 with a range of $0.04 to $0.04. The previous quarter’s EPS was -$0.04. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
DIUXF Sales Forecast
Next quarter’s sales forecast for DIUXF is $37.61M with a range of $37.61M to $37.61M. The previous quarter’s sales results were $23.12M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.